Dechert Advises Special Committee of Enfusion on US$1.5 Billion Acquisition by Clearwater Analytics

Dechert advised the Special Committee of Enfusion, Inc., a leader in SaaS solutions for the investment management and hedge fund industry, on a definitive agreement for Enfusion to be acquired by Clearwater Analytics, a global leading SaaS solution that automates the entire investment lifecycle.

The acquisition of Enfusion accelerates Clearwater’s vision of building the first cloud-native end-to-end platform for the entire investment management industry. This strategic move aims to develop a front-to-back investment management platform that addresses the evolving needs of institutional investors.

The US$1.5 billion transaction is expected to close in Q2 of 2025, pending approval by Enfusion shareholders, the receipt of required regulatory approvals and customary closing conditions.

The team that advised the Special Committee of Enfusion was led by corporate partners Mark E. Thierfelder, Eric S. Siegel and Michael S. Darby as well as litigation partners Andrew J. Levander and Rick S. Horvath, and included antitrust partner James A. Fishkin; employee benefits partner Kevin Kay; corporate partner Sarah Kupferman with counsel Ryan A. Post and associates Mary Kate Alexandre and Callie Maslowsky; global finance partner Soo-ah Nah; and tax partner David J. Passey.

About Dechert

Dechert is a global law firm that advises asset managers, financial institutions and corporations on issues critical to managing their business and their capital – from high-stakes litigation to complex transactions and regulatory matters. We answer questions that seem unsolvable, develop deal structures that are new to the market and protect clients' rights in extreme situations. Our nearly 1,000 lawyers across 19 offices globally focus on the financial services, private equity, private credit, real estate, life sciences and technology sectors.